ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Afqlir 40 mg/ml, Injektionslösung - 
70127001 Sandoz Pharmaceuticals AG
Afqlir 40 mg/ml, Injektionslösung25.09.2025
  25.09.2025
Aflibercept (S01LA05) 
WHO-DDD24.09.2030
 
11.99. 
B  
No 
IP 
   
k.A. 
  
7680701270013Biotechnologika
  
Composition
afliberceptum 2 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, polysorbatum 20, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 0.05 ml corresp. natrium 1.73 µg.
Packungsbestandteile
Injection solution
 
 
Active AgentDose
Afliberceptum2mg / 0.05ml
 
Inactive agents
Acidum Hydrochloridum
Histidin Hydrochloride Monohydrate
Histidine
Sodium Hydroxide
Polysorbatum 20
Trehalosum Dihydricum
Source
Data was imported : 18.12.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home